Article info
PDFOriginal research
Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy
- Correspondence to Dr Julie M Fox, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK; julie.fox{at}kcl.ac.uk
Citation
Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy
Publication history
- Received September 22, 2022
- Accepted December 4, 2022
- First published December 23, 2022.
Online issue publication
August 17, 2023
Article Versions
- Previous version (23 December 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.